Atlas Trials

Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat

Clinical trial NCT00525044 · COMPLETED

Trial details

NCT number
NCT00525044
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pharyngitis
Start date
2007-08-01
Primary completion
2008-01-01
Enrollment
249

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.